Clinical Trial Update: Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on tailored neoadjuvant chemotherapy for stage II/III breast cancer with tumor size >2 cm has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Breast Cancer, Chemotherapy | Phase 3 | Status: COMPLETED